Advertisement
Screener

CAMP4 Therapeutics Corporation (CAMP) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

CAMP4 Therapeutics Corporation Cash Flow Breakdown

Cash flow breakdown shows where CAMP4 Therapeutics Corporation's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $29.55M went out.
  • Fiscal year ended 2025-12-31: from investing, $243.00K went out.
  • Fiscal year ended 2025-12-31: from financing, $75.89M came in.
  • Fiscal year ended 2025-12-31: change in cash, $46.09M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$29.55M-$243.00K$57.52M$18.37M*$46.09M
2024-12-31-$45.56M-$441.00K$76.35M-$4.69M*$25.66M
2023-12-31-$44.16M-$678.00K$0.00-$44.53M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$12.69M*-$129.00K*
2026-03-31-$10.98M$0.00-$10.92M
2025-12-31$6.29M*$0.00*$28.59M*
2025-09-30-$11.22M*$36.00K*$47.38M*
2025-06-30-$10.34M*$0.00*$0.00*
2025-03-31-$14.29M-$279.00K$0.00-$14.72M
2024-12-31-$11.29M*-$263.00K*$76.32M*-$3.26M*
2024-09-30-$9.69M*$0.00*$31.00K*
2024-06-30-$13.44M*-$163.00K*$0.00*-$812.00K*
2024-03-31-$11.14M-$15.00K$2.00K-$11.36M
2023-12-31-$11.78M*-$243.00K*-$12.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51